Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 130.14 million as of April 24, 2025. Its market cap has decreased by -2.04% in one year.

Market Cap

130.14M

Enterprise Value

164.77M

Revenue

42.50M

Ranking

n/a

PE Ratio

9.93

Stock Price

7.03

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 130.73M to 130.14M, a decrease of -0.45%. That is a compound annual growth rate of -0.02%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	132.91M	-13.38%
Dec 30, 2024	153.44M	86.31%
Dec 29, 2023	82.36M	231.73%
Dec 30, 2022	24.83M	5.96%
Dec 30, 2021	23.43M	-26.63%
Dec 30, 2020	31.94M	-64.16%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	157.23B
GSK plc	55.19B
Haleon	34.34B
Smith & Nephew	8.58B
ConvaTec Group	5.21B
Hikma Pharmaceuticals	4.20B
HUTCHMED (China)	2.01B
Oxford Nanopore Technologies	1.13B

Market Cap Rankings